Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alan Meds vs Aurelius Health Group

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

Alan Meds

Best for budget-conscious shoppers
★★★3.9

Starting at $99/mo

CompoundedSemaglutideTirzepatideOral Format
Visit Alan Meds
6.2

Aurelius Health Group

Best for Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly.
★★★☆☆3.1

Starting at $89/mo

Compounded tirzepatide MICRODOSING protocol (dual GIP + GLP-1, low-dose)Transparent published pricing: $89 first month, then $199/monthPrice includes physician consults, full protocol, shipping, monthly check-ins, secure messaging, HIPAA platformStackable add-ons: NAD+, L-carnitine, B12, or inositol
Visit Aurelius Health Group

Side-by-Side Comparison

FeatureAlan MedsAurelius Health Group
Overall Score7.7/106.2/10
Starting Price$99/mo$89/mo
Editorial Rating3.9 ★ /53.1 ★ /5
Features5 features6 features
States Available460
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alan Meds

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Cons

  • Limited public information on program details

Aurelius Health Group

Pros

  • Pricing is fully published and bundled ($89 first month / $199/mo all-in) — more transparent than many compounded-GLP-1 DTC brands
  • LegitScript-certified seal displayed
  • Care-inclusive model (consults + monthly monitoring + secure messaging) rather than transactional Rx-only
  • Unusually candid about the limited evidence base for microdosing

Cons

  • MICRODOSE-only model — sub-therapeutic doses have a thinner RCT evidence base than the FDA-approved full-dose tirzepatide regimen (the site acknowledges this); expect smaller weight-loss effect than standard dosing
  • No semaglutide / standard full-dose option disclosed
  • No named compounding pharmacy partner
  • No specific state list and no named medical director / PIC disclosed
  • LegitScript ID number not captured at verification (seal present)

Our Verdict

Winner: Alan MedsScore: 7.7/10

Alan Meds edges out Aurelius Health Group with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Aurelius Health Group remains a solid alternative, especially if you're looking for Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly..

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Alan Meds and Aurelius Health Group head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.